Shares of Intra-Cellular Therapies Inc. (NASDAQ:ITCI) are trading higher Monday after Johnson & Johnson agreed to acquire the company. What To Know: Johnson & Johnson on Monday entered into a ...
Track the latest Intra-Cellular Therapies insider trading activity. Stay informed on recent buys, sells, and market impact for Intra-Cellular Therapies stock. Insider trading activity involves company ...
Transactions among affiliated companies of the nation’s major business groups have increased again this year, with most of the deals being made without fair competition, the state-run antitrust ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback